title: A controlled trial comparing sequential antilymphocyte sera and cyclosporine therapy to conventional therapy in renal transplant recipients.
authors.affiliation: Department of Medicine, Toronto Western Hospital, Ontario, Canada.
authors.forename: C J
authors.initials: CJ
authors.lastname: Cardella
authors.forename: M E
authors.initials: ME
authors.lastname: Harding
authors.forename: G A
authors.initials: GA
authors.lastname: deVeber
authors.forename: J
authors.initials: J
authors.lastname: Honey
authors.forename: G T
authors.initials: GT
authors.lastname: Cook
mesh_terms: D000961:Antilymphocyte Serum / Q000008:administration & dosage / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D016030:Kidney Transplantation / Q000276:immunology*; D011241:Prednisone / Q000627:therapeutic use
chemical_list: D000961:Antilymphocyte Serum; D003524:Cyclosporins; D001379:Azathioprine; D011241:Prednisone